TY - JOUR
KW - Adult
KW - Agranulocytosis
KW - Dapsone
KW - Female
KW - Humans
KW - Leprostatic Agents
KW - leprosy
AU - Hiran S
AU - Pande T K
AU - Pani S
AU - Vishwanathan K A
AB - <p>Dapsone-induced agranulocytosis is a rare adverse effect. There are various reports of agranulocytosis in patients treated with dapsone for malaria prophylaxis and other dermatological diseases. However, this adverse reaction in leprosy is not often encountered. We describe agranulocytosis in a young patient who was taking dapsone (100 mg) for borderline-tuberculoid leprosy in a rural environment.</p>
BT - Leprosy review
C1 - http://www.ncbi.nlm.nih.gov/pubmed/8942159?dopt=Abstract
CN - Infolep Library - available
DA - 1994 Sep
DO - 10.5935/0305-7518.19940028
IS - 3
J2 - Lepr Rev
LA - eng
N2 - <p>Dapsone-induced agranulocytosis is a rare adverse effect. There are various reports of agranulocytosis in patients treated with dapsone for malaria prophylaxis and other dermatological diseases. However, this adverse reaction in leprosy is not often encountered. We describe agranulocytosis in a young patient who was taking dapsone (100 mg) for borderline-tuberculoid leprosy in a rural environment.</p>
PY - 1994
SP - 279
EP - 81
T2 - Leprosy review
TI - Dapsone agranulocytosis in a leprosy patient.
UR - http://leprev.ilsl.br/pdfs/1994/v65n3/pdf/v65n3a15.pdf
VL - 65
SN - 0305-7518
ER -